Physician profile
Eileen M Rodriguez
NPI 1306435151
$2,779.61
in general payments reported to CMS, 2019-2025
21 companies · $778 in 2025
The $778 reported for 2025 was more than what 80% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $203 · 2022: $404 · 2023: $411 · 2024: $984 · 2025: $778.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,860 · Travel and Lodging: $313.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,859.87 |
| Travel and Lodging | $312.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tandem Diabetes Care, INC. | $553.42 | 2021-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Medtronic, INC. | $536.94 | 2024-2025 | Minimed 780g |
| Abbvie INC. | $348.77 | 2024 | |
| Novo Nordisk INC | $267.91 | 2021-2025 | Ozempic |
| Nevro Corp. | $170.33 | 2022-2024 | Senza |
| Beta Bionics, INC. | $139.85 | 2023-2024 | Ilet Bionic Pancreas |
| Boehringer Ingelheim Pharmaceuticals, INC. | $125.00 | 2024 | Jardiance |
| Dexcom, INC. | $108.61 | 2024-2025 | Dexcom G6 Transmitter |
| Corcept Therapeutics | $97.79 | 2024 | Korlym |
| Abbott Laboratories | $78.97 | 2022-2024 | Freestyle Libre 3 |
| Lilly USA, LLC | $61.78 | 2022-2023 | Jardiance |
| Pfizer INC. | $55.00 | 2022 | |
| Amneal Pharmaceuticals LLC | $46.47 | 2023-2025 | Unithroid |
| Sanofi-Aventis U.S. LLC | $43.79 | 2021-2023 | |
| Antares Pharma, INC. | $37.41 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eagle Pharmaceuticals, INC. | $22.21 | 2024 | |
| Microtransponder, INC. | $21.50 | 2025 | |
| Novartis Pharmaceuticals Corporation | $18.88 | 2023 | |
| Ascensia Diabetes Care US INC. | $15.80 | 2022 | |
| Sequel Med Tech, LLC | $15.29 | 2025 | Twiist |
| Amgen INC. | $13.89 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eileen Rodriguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.